Fig. 4: Upfront resectable (left panels) and borderline resectable (right panels) in the central tertiary centre multidisciplinary team resectability assessment compared with resectability assessment in local hospitals done before systemic therapy and recruitment to the RAXO trial. | British Journal of Cancer

Fig. 4: Upfront resectable (left panels) and borderline resectable (right panels) in the central tertiary centre multidisciplinary team resectability assessment compared with resectability assessment in local hospitals done before systemic therapy and recruitment to the RAXO trial.

From: Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study

Fig. 4

a and b RAS and BRAF wild type patients. c and d RAS mutated type patients. e and f BRAF mutated type patients.

Back to article page